The administration of the triple combination was stopped in three patients because of adverse effects: elevated levels of SGOT, SGPT, CPK and myopathy in the first; elevated levels of bilirubin in the second; and constipation in the third [9]. The gene discussed is GOT1; the disease is myopathy.